TRIB3 and nonpapillary renal cell carcinoma: Kaplan–Meier survival analysis of TCGA ccRCC dataset showed that patients with high TRIB3-expressing tumors had significantly shorter survival times than patients with low TRIB3-expressing tumors (Figure 2(a), p < 0.001).